News Search

With funding from ARPA-H, a team led by Columbia researchers plans to build an implantable device—filled with engineered cells—that regulates appetite, digestion, and blood sugar.

View the CUIMC Update, a weekly e-newsletter featuring medical center news and the accomplishments of our faculty, staff, and trainees.

For National Disability Employment Awareness Month, we spoke with employees who identify as people with disabilities about their experiences working at Columbia.

Combining a diabetes drug with a cancer drug not only kills aggressive bladder cancer cells in mice, but also turns remaining malignant cells into a more benign state.